drugset / Trial / NCT00218231
Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
RandomizedCrossoverDouble-blindTreatment
Summary
Many individuals with schizophrenia smoke cigarettes but little is known about the factors that control smoking in people with schizophrenia. The purpose of this trial is to evaluate how bupropion, an antidepressant medication, affects smoking behaviors in individuals with schizophrenia who smoke.
Timeline
- Start
- 2004-01
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | — |